Posted inBiotechnology
How Chromosomes Find Their Matching Partners
For decades, vast stretches of the animal genome were dismissed as genetic “junk”—repetitive DNA sequences that do not encode proteins…
Posted inMedical Technology
Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test
Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.
Posted inBiotechnology
Triglyceride-Glucose Index Linked to Elevated Blood Pressure in U.S. Teens
A simple calculation from two routine blood tests is drawing new attention to a question that could affect millions of…
Posted inBiotechnology
National Poll: Many Parents Struggle to Serve Kids Healthy Breakfast Before School
As families across the United States rebuild school-day routines, a familiar morning problem is taking on new significance: how to…
Posted inBiotechnology
Turning Wastewater Disposal into Reuse
Researchers in Japan have developed a wastewater treatment technology that could transform nitrogen pollution from an environmental liability into a…
Posted inBiotechnology
Shoulders Bear the Brunt of Changes in Bone Mineral Density
A new study from Osaka Metropolitan University is drawing attention to an overlooked consequence of shoulder replacement surgery: the gradual…
Posted inBiotechnology
New book explores loss as a central part of pregnancy
Pregnancy Is a High-Stakes Biological Trial, and Loss Is Its Most Common Outcome Pregnancy is often described as a predictable…
Posted inBiotechnology
Extreme Heat Drives Low-Income Households Toward Payday Loans, Study Finds
Extreme heat and bitter cold are usually reported as threats to health, infrastructure and agriculture. A new study published in…
Posted inBiotechnology
Immune Cell Profiles Reveal Disease Mechanisms in Children With IgA Vasculitis, Thrombocytopenia
IgA vasculitis and immune thrombocytopenia are among the most frequently encountered immune-mediated disorders in children, yet they affect the body…
Posted inBiotechnology
Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
Roche has taken its obesity strategy into uncharted territory via a $190 million upfront payment for a clinical-stage urocortin-2 analog…